Reassessing The Changing Outlook For Lilly(Eli) & Co (LLY)

Currently, there are 947.54M common shares owned by the public and among those 849.99M shares have been available to trade.

The company’s stock has a 5-day price change of 11.69% and 12.72% over the past three months. LLY shares are trading 5.96% year to date (YTD), with the 12-month market performance up to 8.96% higher. It has a 12-month low price of $677.09 and touched a high of $972.53 over the same period. LLY has an average intraday trading volume of 3.70 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.03%, -1.99%, and -3.39% respectively.

Institutional ownership of Lilly(Eli) & Co (NYSE: LLY) shares accounts for 73.04% of the company’s 947.54M shares outstanding.

It has a market capitalization of $775.47B and a beta (3y monthly) value of 0.48. The stock’s trailing 12-month PE ratio is 71.20, while the earnings-per-share (ttm) stands at $11.49. The company has a PEG of 1.69 and a Quick Ratio of 0.89 with the debt-to-equity ratio at 2.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.56% over the week and 4.32% over the month.

Analysts forecast that Lilly(Eli) & Co (LLY) will achieve an EPS of 3.91 for the current quarter, 5.51 for the next quarter and 29.61 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 2.68 while analysts give the company a high EPS estimate of 2.68. Comparatively, EPS for the current quarter was 2.58 a year ago. Earnings per share for the fiscal year are expected to increase by 74.38%, and 31.82% over the next financial year. EPS should grow at an annualized rate of 42.03% over the next five years, compared to 18.77% over the past 5-year period.

Looking at the support for the LLY, a number of firms have released research notes about the stock. BofA Securities stated their Buy rating for the stock in a research note on December 10, 2024, with the firm’s price target at $997. Wolfe Research coverage for the Lilly(Eli) & Co (LLY) stock in a research note released on November 15, 2024 offered a Outperform rating with a price target of $1000. Bernstein was of a view on October 17, 2024 that the stock is Outperform, while Citigroup gave the stock Buy rating on September 13, 2024, issuing a price target of $1060. Deutsche Bank on their part issued Buy rating on August 12, 2024.

Most Popular

Related Posts